Press Release for the Audited Financial Results of the Company for the quarter and year ended on March 31, 2026

Revenue Growth 20pctPat Growth 25pctEbitda Margin ExpansionResults View source PDF Explain this filing

ADVANCE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.3%Reaction day

₹112.32

prior close

₹116.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.4%+1.1% vs market

Pesticides & Agrochemicals peers, median of 28sector-1.6%+1.3% vs sector

On the reaction day the stock moved 1.1 pts more than Nifty Microcap 250 and 1.3 pts more than its Pesticides & Agrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-2.5

10m

-1.6

15m

-1.5

30m

-3.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.3-1.4+1.1-1.6+1.3

Next day

-5.1-4.5-0.6-3.5-1.6

-7.4-3.8-3.6-3.6-3.8

-7.5-3.6-4.0-3.5-4.0

-8.7-3.9-4.8-4.3-4.4

-10.3-5.2-5.1-5.9-4.4

-10.4-4.2-6.2-5.4-5.0

15d

-9.2-1.5-7.7-7.6-1.6

-14.8-3.1-11.7-8.2-6.6

+1.2+6.4-5.2-6.0+7.2

+8.8+8.3+0.5-4.2+13.0

UpDownMarket · Nifty Microcap 250Sector · Pesticides & Agrochemicals peers, median of 28Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Advance Agrolife delivered strong growth in FY26 with revenue of ₹6,417.5 million, up 28% YoY, and PAT of ₹352.84 million, up 38% YoY. Q4 FY26 showed even stronger momentum with revenue up 40% to ₹1,259.07 million and PAT surging 422% to ₹74.61 million. EBITDA margin expanded significantly to 9.99% for the year and 10.8% in Q4, up 50 bps and 425 bps respectively. The company strengthened its manufacturing capabilities with backward integration for Pretilachlor Technical, received a credit rating upgrade from CARE Ratings (BBB to BBB+), and announced expansion plans including a new Unit-4 facility at Gidani and land acquisition MOU for Unit-5 at Dahej.

Likely market impact

The company demonstrated robust financial performance in its maiden year post-listing with strong revenue growth, margin expansion, and exceptional PAT growth, particularly in Q4. The credit rating upgrade signals improving financial health, while expansion plans indicate a positive long-term growth outlook for shareholders.